Stelios Papadopoulos
Affiliations
- at Regulus Therapeutics Inc. (RGLS), 2024-03-15
- Director at Exelixis Inc. (EXEL), 2023-06-03
- Director at Biogen Inc. (BIIB), 2022-06-17
- Large Shareholder, Director at Eucrates Biomedical Acquisition Corp. (EUCR), 2020-11-27
- Director at Bg Medicine Inc. (BGMD), 2015-11-20
- Director at Anadys Pharmaceuticals Inc (ANDS), 2011-05-27
Insider Trading: Purchases See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| RGLS | $1.08 | 370,370 | Director | 1,189,872 | 2019-05-07 | Filing | |
| RGLS | $1.09 | 50,000 | Director | 835,073 | 2018-12-28 | Filing | |
| RGLS | $1.04 | 26,401 | Director | 785,073 | 2018-12-27 | Filing | |
| RGLS | $0.95 | 90,000 | Director | 758,672 | 2018-12-26 | Filing | |
| RGLS | $1.38 | 300,000 | Director | 668,672 | 2018-11-16 | Filing |
Insider Trading: Sales See All
| Company | Symbol | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|---|
| EXEL | $19.56 | 84,515 | Director | 1,220,036 | 2022-02-22 | Filing | |
| EXEL | $25.01 | 5,473 | Director | 1,288,127 | 2021-05-11 | Filing | |
| EXEL | $25.00 | 5,075 | Director | 1,253,600 | 2021-05-11 | Filing | |
| EXEL | $24.95 | 10,222 | Director | 1,218,675 | 2021-05-11 | Filing | |
| EXEL | $25.84 | 45,000 | Director | 1,052,568 | 2020-05-08 | Filing |